[1]
S. Sharma and V. Bhatia, “Treatment of Type 2 diabetes mellitus (T2DM): Can GLP-1 Receptor Agonists fill in the gaps?”, Chem Biol Lett, vol. 7, no. 4, pp. 215–224, Aug. 2020, Accessed: Jul. 22, 2024. [Online]. Available: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/132